Celiac.com Sponsor (A1):

Join eNewsletter

Celiac.com Sponsor (A1-m):


Join eNewsletter

  • Join Our Community!

    Ask us a question in our celiac / gluten-free forum.

  • Jefferson Adams

    Celiac Disease on Agenda for FDA Gastro Meeting

    Jefferson Adams

    By Jefferson Adams •

    0
    Reviewed and edited by a celiac disease expert.

    Celiac.com 10/14/2015 - For the past few years, the FDA has held an annual public workshop to discuss the selection of end points and clinical outcome measures appropriate for drug development in GI diseases.

    FDA logo. Image: Wikimedia Commons.This spring, for the first time, celiac disease made it onto the agenda of the Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics (GREAT 3) meeting. At the meeting, experts discussed the challenges of identifying an appropriate target population for pharmacologic therapy, defining and measuring efficacy in clinical trials for celiac disease, and the timing of assessment end points.


    Celiac.com Sponsor (A12):




    Celiac.com Sponsor (A12-m):



    GREAT 3 was held March 30 to 31, 2015, and was cosponsored by the American College of Gastroenterology; American Gastroenterological Association; Crohn's & Colitis Foundation of America; North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition; Pediatric IBD Foundation; and North American Society for the Study of Celiac Disease.

    Among the topics covered at the first GREAT devoted to celiac disease and related issues, were discussions of the appropriate target population for pharmacological therapy in celiac disease, and the definition and measurement of efficacy in celiac disease clinical trials intended to support marketing approval, including the role and timing of assessment of specific endpoints.

    There was also much discussion of the need for pharmacologic treatments to accelerate healing in patients with untreated celiac disease and reduce the risks for long-term consequences of ongoing inflammation, even when inflammation is symptomatic.

    Read More at GREAT3.org.

    0
    Go to articles

    User Feedback

    Recommended Comments

    There are no comments to display.



    Join the conversation

    You are posting as a guest. If you have an account, sign in now to post with your account.
    Note: Your post will require moderator approval before it will be visible.

    Guest
    Add a comment...

    ×   Pasted as rich text.   Restore formatting

      Only 75 emoji are allowed.

    ×   Your link has been automatically embedded.   Display as a link instead

    ×   Your previous content has been restored.   Clear editor

    ×   You cannot paste images directly. Upload or insert images from URL.

    ×

  • About Me

    Jefferson Adams

    Jefferson Adams is Celiac.com's senior writer and Digital Content Director. He earned his B.A. and M.F.A. at Arizona State University, and has authored more than 2,500 articles on celiac disease. His coursework includes studies in science, scientific methodology, biology, anatomy, medicine, logic, and advanced research. He previously served as SF Health News Examiner for Examiner.com, and devised health and medical content for Sharecare.com. Jefferson has spoken about celiac disease to the media, including an appearance on the KQED radio show Forum, and is the editor of the book "Cereal Killers" by Scott Adams and Ron Hoggan, Ed.D.

  • Celiac.com Sponsor (A17):
    Celiac.com Sponsor (A17):



    Celiac.com Sponsors (A17-m):



  • Related Articles

    Jefferson Adams
    Celiac.com 09/12/2013 - Good news for consumers of gluten-free foods and other products: The FDA's new standards for the labeling of gluten-free food and other products apply to all foods and products labeled gluten-free, including dietary supplements and vitamins.
    The FDA rules state that any product declaring the contents to be "gluten-free," "no gluten," "free of gluten" or "without gluten," must meet all parts of FDA's gluten-free definition, including the requirement that the food contains less than 20 parts per million of gluten.
    People with celiac disease who consume gluten from wheat, rye, or barley risk gradual damage to the intestines...
    Jefferson Adams
    Celiac.com 01/03/2014 - The United State Food and Drug Administration (FDA) has clarified what their recent gluten-free rule means for restaurants. When the FDA announced its gluten-free labeling standard in August, the agency said that, for restaurants, “any use of an FDA-defined food labeling claim (such as “fat free” or “low cholesterol”) on restaurant menus should be consistent with the respective regulatory definitions.
    The agency noted this same approach would now be followed with respect to “gluten-free” claims made in restaurants and other retail food service establishments.
    The FDA's updated Question & Answer, #9 under ‘Labeling’, n...
    Jefferson Adams
    Celiac.com 08/21/2014 - It’s official! Since August 5th, 2014, all packaged foods sold in the U.S must comply with new federal rules for labeling foods as "gluten-free." That means that all packaged food claiming to be "gluten-free" must contain less than 20 parts per million (ppm) of gluten.
    The FDA finalized the rule in August 2013, and gave food manufacturers one year to comply. The rule went into full effect on August 5, 2014. The new standard applies equally to all products labelled “gluten free,” “no gluten,” “without gluten,” and “free of gluten.”
    Until this rule went into effect, many food and product manufacturers were applying the term...
    Jefferson Adams
    Celiac.com 03/18/2015 - A man who suffers from celiac disease has sued the FDA for allowing gluten to be used as a coating on prescription drug and over-the-counter medicine capsules.
    Remember, people with celiac disease can suffer intestinal damage when they consume gluten. This can damage can lead to neurological, among other disorders.
    The man, Michael Weber, was taking a generic drug seven years ago, and developed side effects consistent with ingesting gluten.
    Weber says he was unable to determine the drug’s gluten status through his pharmacist, and
    Weber went on to petition the FDA to either eliminate wheat gluten i...